Czarnik Tomasz, Gawda Ryszard, Nowotarski Jakub
Department of Anesthesiology and Critical Care, PS ZOZ Wojewodzkie Centrum Medyczne w Opolu, Aleja Witosa 26, 45-418 Opole, Poland.
Department of Anesthesiology and Critical Care, PS ZOZ Wojewodzkie Centrum Medyczne w Opolu, Aleja Witosa 26, 45-418 Opole, Poland.
J Crit Care. 2015 Jun;30(3):624-8. doi: 10.1016/j.jcrc.2015.01.002. Epub 2015 Jan 8.
The cannulation of the axillary vein for renal replacement therapy is a rarely performed procedure in the critical care unit. We defined the venipuncture and catheterization success rates and early mechanical complication rates of this technique in critical care patients with acute kidney injury.
Twenty-nine mechanically ventilated patients with clinical indications for insertion of temporary hemodialysis catheters enrolled in a registered trial (NCT01919528) as a pilot cohort. We performed 29 real-time, ultrasound-guided infraclavicular axillary vein cannulation attempts for renal replacement therapy. We defined the venipuncture and catheterization success rates and early mechanical complication rates for this technique.
The puncture of the axillary vein was successful in 28 (96.5%) patients. In 22 patients (75.9%), venipuncture occurred during the first attempt and in 6 patients during the second (20.7%). The overall cannulation success rate was 93.1% (95% confidence interval, 77%-99%). We noted 6.8% potentially serious complications rate, 10.3% minor complications rate, and 0% life-threatening early mechanical complications. We achieved an 89.6% renal replacement therapy success rate and low rate of catheters malfunction.
Real-time, ultrasound-guided, infraclavicular axillary vein cannulation for renal replacement therapy in the critical care unit is a reliable method of dual-lumen hemodialysis catheter insertion and can be considered a reasonable alternative to jugular and femoral routes in special clinical circumstances.
在重症监护病房,为进行肾脏替代治疗而进行腋静脉置管是一种很少实施的操作。我们确定了该技术在急性肾损伤重症监护患者中的静脉穿刺成功率、置管成功率以及早期机械并发症发生率。
29例有临时血液透析导管置入临床指征的机械通气患者作为试验队列纳入一项注册试验(NCT01919528)。我们进行了29次实时、超声引导下的锁骨下腋静脉置管尝试以进行肾脏替代治疗。我们确定了该技术的静脉穿刺成功率、置管成功率以及早期机械并发症发生率。
28例(96.5%)患者的腋静脉穿刺成功。22例患者(75.9%)在首次尝试时实现静脉穿刺,6例患者(20.7%)在第二次尝试时实现。总体置管成功率为93.1%(95%置信区间,77%-99%)。我们注意到潜在严重并发症发生率为6.8%,轻微并发症发生率为10.3%,早期机械性危及生命并发症发生率为0%。我们实现了89.6%的肾脏替代治疗成功率以及较低的导管故障发生率。
在重症监护病房,实时、超声引导下的锁骨下腋静脉置管用于肾脏替代治疗是一种可靠的双腔血液透析导管置入方法,在特殊临床情况下可被视为颈内静脉和股静脉置管途径的合理替代方法。